{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:58:57Z","timestamp":1788980337871,"version":"build-2803163510"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>Ischemic stroke (IS) refers to local brain tissue necrosis which is caused by impaired blood supply to the carotid artery or vertebrobasilar artery system. As the second leading cause of death in the world, IS has a high incidence and brings a heavy economic burden to all countries and regions because of its high disability rate. In order to effectively treat IS, a large number of drugs have been designed and developed. However, most drugs with good therapeutic effects confirmed in preclinical experiments have not been successfully applied to clinical treatment due to the low accumulation efficiency of drugs in IS areas after systematic administration. As an emerging strategy for the treatment of IS, stimuli-responsive nanomedicines have made great progress by precisely delivering drugs to the local site of IS. By response to the specific signals, stimuli-responsive nanomedicines change their particle size, shape, surface charge or structural integrity, which enables the enhanced drug delivery and controlled drug release within the IS tissue. This breakthrough approach not only enhances therapeutic efficiency but also mitigates the side effects commonly associated with thrombolytic and neuroprotective drugs. This review aims to comprehensively summarize the recent progress of stimuli-responsive nanomedicines for the treatment of IS. Furthermore, prospect is provided to look forward for the better development of this field.<\/jats:p>","DOI":"10.3389\/fbioe.2023.1329959","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T23:36:59Z","timestamp":1706830619000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Application of stimuli-responsive nanomedicines for the treatment of ischemic stroke"],"prefix":"10.3389","volume":"11","author":[{"given":"Yongyi","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhejing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1056\/NEJMoa1713973","article-title":"Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging","volume":"378","author":"Albers","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2147\/ijn.S231853","article-title":"Nanocarriers for stroke therapy: advances and obstacles in translating animal studies","volume":"15","author":"Alkaff","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jamaneurol.2016.5815","article-title":"Assessment of the predictive validity of etiologic stroke classification","volume":"74","author":"Arsava","year":"2017","journal-title":"JAMA Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1021\/acs.chemrev.1c00622","article-title":"Ultrasound-responsive systems as components for smart materials","volume":"122","author":"Athanassiadis","year":"2022","journal-title":"Chem. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2100118","DOI":"10.1002\/sstr.202100118","article-title":"Photothermal-activatable liposome carrying tissue plasminogen activator for photoacoustic image-guided ischemic stroke treatment","volume":"3","author":"Cai","year":"2022","journal-title":"Small Struct."},{"key":"B7","doi-asserted-by":"publisher","first-page":"100791","DOI":"10.1016\/j.eclinm.2021.100791","article-title":"Associations of behaviors, biological phenotypes and cardiovascular health with risks of stroke and stroke subtypes: a prospective cohort study","volume":"33","author":"Cao","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/s1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1097\/cm9.0000000000001856","article-title":"Initial establishment of a stroke management model in China: 10 years (2011-2020) of stroke prevention project committee, national health commission","volume":"134","author":"Chao","year":"2021","journal-title":"Chin. Med. J. Engl."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1177151","DOI":"10.3389\/fbioe.2023.1177151","article-title":"Advances in nanomaterial-based targeted drug delivery systems","volume":"11","author":"Cheng","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"56909","DOI":"10.1021\/acsami.1c16530","article-title":"pH-responsive multifunctional theranostic rapamycin-loaded nanoparticles for imaging and treatment of acute ischemic stroke","volume":"13","author":"Cheng","year":"2021","journal-title":"ACS Appl. Mater Interfaces"},{"key":"B12","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s12975-020-00868-z","article-title":"Refined ischemic penumbra imaging with tissue pH and diffusion kurtosis magnetic resonance imaging","volume":"12","author":"Cheung","year":"2021","journal-title":"Transl. Stroke Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1021\/acsnano.0c09115","article-title":"Harnessing endogenous stimuli for responsive materials in theranostics","volume":"15","author":"Cook","year":"2021","journal-title":"ACS Nano"},{"key":"B14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jconrel.2019.07.017","article-title":"In vivo ultrasound-activated delivery of recombinant tissue plasminogen activator from the cavity of sub-micrometric capsules","volume":"308","author":"Correa-Paz","year":"2019","journal-title":"J. Control Release"},{"key":"B15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jconrel.2016.01.028","article-title":"pH gradient difference around ischemic brain tissue can serve as a trigger for delivering polyethylene glycol-conjugated urokinase nanogels","volume":"225","author":"Cui","year":"2016","journal-title":"J. Control Release"},{"key":"B16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/17425247.2022.2110585","article-title":"State-of-the-art of ultrasound-triggered drug delivery from ultrasound-responsive drug carriers","volume":"19","author":"Fan","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"B17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41582-021-00605-6","article-title":"Pharmacological brain cytoprotection in acute ischaemic stroke - renewed hope in the reperfusion era","volume":"18","author":"Fisher","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/s1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","year":"2019","journal-title":"Lancet Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuron.2015.05.041","article-title":"Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments","volume":"87","author":"George","year":"2015","journal-title":"Neuron"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1007\/s12035-021-02496-6","article-title":"NIR laser photobiomodulation induces neuroprotection in an in vitro model of cerebral hypoxia\/ischemia","volume":"58","author":"Gerace","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/0271678x211028816","article-title":"Endovascular administration of magnetized nanocarriers targeting brain delivery after stroke","volume":"42","author":"Grayston","year":"2022","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1161\/strokeaha.119.026402","article-title":"Association of lipids with ischemic and hemorrhagic stroke: a prospective cohort study among 267 500 Chinese","volume":"50","author":"Gu","year":"2019","journal-title":"Stroke"},{"key":"B23","doi-asserted-by":"publisher","first-page":"8723","DOI":"10.1021\/acsnano.8b04787","article-title":"Thrombin-responsive, brain-targeting nanoparticles for improved stroke therapy","volume":"12","author":"Guo","year":"2018","journal-title":"ACS Nano"},{"key":"B24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/brain\/awu374","article-title":"Identifying the ischaemic penumbra using pH-weighted magnetic resonance imaging","volume":"138","author":"Harston","year":"2015","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e2001647","DOI":"10.1002\/smll.202001647","article-title":"Thrombolytic agents: nanocarriers in controlled release","volume":"16","author":"Hassanpour","year":"2020","journal-title":"Small"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1021\/acs.nanolett.1c00231","article-title":"Preferential targeting cerebral ischemic lesions with cancer cell-inspired nanovehicle for ischemic stroke treatment","volume":"21","author":"He","year":"2021","journal-title":"Nano Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/ccm.0000000000004597","article-title":"Management of acute ischemic stroke","volume":"48","author":"Herpich","year":"2020","journal-title":"Crit. Care Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/s0140-6736(20)30258-0","article-title":"Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial","volume":"395","author":"Hill","year":"2020","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"32988","DOI":"10.1021\/acsami.8b09423","article-title":"Tissue plasminogen activator-porous magnetic microrods for targeted thrombolytic therapy after ischemic stroke","volume":"10","author":"Hu","year":"2018","journal-title":"ACS Appl. Mater Interfaces"},{"key":"B30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biomaterials.2018.05.009","article-title":"Glycosaminoglycan-based hybrid hydrogel encapsulated with polyelectrolyte complex nanoparticles for endogenous stem cell regulation in central nervous system regeneration","volume":"174","author":"Jian","year":"2018","journal-title":"Biomaterials"},{"key":"B31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bioactmat.2022.03.040","article-title":"ROS-responsive 18\u03b2-glycyrrhetic acid-conjugated polymeric nanoparticles mediate neuroprotection in ischemic stroke through HMGB1 inhibition and microglia polarization regulation","volume":"19","author":"Jin","year":"2023","journal-title":"Bioact. Mater"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJMoa2207576","article-title":"Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion","volume":"387","author":"Jovin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"102178","DOI":"10.1016\/j.redox.2021.102178","article-title":"In vivo dynamics of acidosis and oxidative stress in the acute phase of an ischemic stroke in a rodent model","volume":"48","author":"Kelmanson","year":"2021","journal-title":"Redox Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"122570","DOI":"10.1016\/j.ijpharm.2022.122570","article-title":"Nanocarriers based novel and effective drug delivery system","volume":"632","author":"Khizar","year":"2023","journal-title":"Int. J. Pharm."},{"key":"B35","doi-asserted-by":"publisher","first-page":"119942","DOI":"10.1016\/j.biomaterials.2020.119942","article-title":"Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke","volume":"243","author":"Kim","year":"2020","journal-title":"Biomaterials"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1177\/0271678x17700913","article-title":"Imaging the physiological evolution of the ischemic penumbra in acute ischemic stroke","volume":"38","author":"Leigh","year":"2018","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1021\/acsabm.8b00644","article-title":"RGD modified protein-polymer conjugates for pH-triggered targeted thrombolysis","volume":"2","author":"Li","year":"2019","journal-title":"ACS Appl. Bio Mater"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.apsb.2020.11.019","article-title":"Recent advances in nanomedicines for the treatment of ischemic stroke","volume":"11","author":"Li","year":"","journal-title":"Acta Pharm. Sin. B"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1021\/acsnano.9b08587","article-title":"Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1002\/anie.202010391","article-title":"Ultrasound controlled anti-inflammatory polarization of platelet decorated microglia for targeted ischemic stroke therapy","volume":"60","author":"Li","year":"","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B41","doi-asserted-by":"publisher","first-page":"885190","DOI":"10.3389\/fncel.2022.885190","article-title":"Recent advances in nanomaterials for diagnosis, treatments, and neurorestoration in ischemic stroke","volume":"16","author":"Lin","year":"2022","journal-title":"Front. Cell Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"15135","DOI":"10.1002\/anie.202004017","article-title":"In situ formation of polymeric nanoassemblies using an efficient reversible click reaction","volume":"59","author":"Liu","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B43","doi-asserted-by":"publisher","first-page":"18806","DOI":"10.1021\/acsnano.2c07581","article-title":"Biocompatible iron oxide nanoring-labeled mesenchymal stem cells: an innovative magnetothermal approach for cell tracking and targeted stroke therapy","volume":"16","author":"Liu","year":"","journal-title":"ACS Nano"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e2208995","DOI":"10.1002\/adma.202208995","article-title":"From nanoscopic to macroscopic materials by stimuli-responsive nanoparticle aggregation","volume":"35","author":"Liu","year":"","journal-title":"Adv. Mater"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1808361","DOI":"10.1002\/adma.201808361","article-title":"Microthrombus-targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke","volume":"31","author":"Lu","year":"2019","journal-title":"Adv. Mater"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8043","DOI":"10.7150\/thno.60785","article-title":"Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury","volume":"11","author":"Luo","year":"2021","journal-title":"Theranostics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1021\/acsnano.8b00477","article-title":"Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment","volume":"12","author":"Lv","year":"2018","journal-title":"ACS Nano"},{"key":"B48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/10717544.2021.1879315","article-title":"Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke","volume":"28","author":"Ma","year":"2021","journal-title":"Drug Deliv."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1161\/strokeaha.121.038400","article-title":"Temporal trends of functional outcome in patients with acute ischemic stroke treated with intravenous thrombolysis","volume":"53","author":"Marko","year":"2022","journal-title":"Stroke"},{"key":"B50","doi-asserted-by":"publisher","first-page":"119209","DOI":"10.1016\/j.biomaterials.2019.05.020","article-title":"Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - synergistic effect of thrombolysis and antioxidant","volume":"215","author":"Mei","year":"2019","journal-title":"Biomaterials"},{"key":"B51","doi-asserted-by":"publisher","first-page":"689","DOI":"10.7150\/thno.64806","article-title":"Dodging blood brain barrier with \"nano\" warriors: novel strategy against ischemic stroke","volume":"12","author":"Parvez","year":"2022","journal-title":"Theranostics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.biomaterials.2017.03.012","article-title":"Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis","volume":"128","author":"Pawlowski","year":"2017","journal-title":"Biomaterials"},{"key":"B53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41392-022-01064-1","article-title":"Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jconrel.2017.04.003","article-title":"Spatio-temporal control strategy of drug delivery systems based nano structures","volume":"255","author":"Rahoui","year":"2017","journal-title":"J. Control Release"},{"key":"B55","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jconrel.2021.07.024","article-title":"Near-infrared light-responsive liposomes for protein delivery: towards bleeding-free photothermally-assisted thrombolysis","volume":"337","author":"Refaat","year":"2021","journal-title":"J. Control Release"},{"key":"B56","doi-asserted-by":"publisher","first-page":"10802","DOI":"10.3390\/ijms241310802","article-title":"Nanodrugs for the treatment of ischemic stroke: a systematic review","volume":"24","author":"Ruscu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1600124","DOI":"10.1002\/advs.201600124","article-title":"Reactive-oxygen-species-responsive drug delivery systems: promises and challenges","volume":"4","author":"Saravanakumar","year":"2017","journal-title":"Adv. Sci. (Weinh)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1021\/acsnano.8b01772","article-title":"Erythrocyte membrane modified Janus polymeric motors for thrombus therapy","volume":"12","author":"Shao","year":"2018","journal-title":"ACS Nano"},{"key":"B59","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00401-022-02452-1","article-title":"Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic stroke","volume":"144","author":"Spitzer","year":"2022","journal-title":"Acta Neuropathol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijbiomac.2022.06.102","article-title":"Novel multifunctional bionanoparticles modified with sialic acid for stroke treatment","volume":"214","author":"Su","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bioactmat.2017.08.001","article-title":"In vivo evaluation of urokinase-loaded hollow nanogels for sonothrombolysis on suture embolization-induced acute ischemic stroke rat model","volume":"3","author":"Teng","year":"2018","journal-title":"Bioact. Mater"},{"key":"B62","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41582-022-00703-z","article-title":"The neurovascular unit and systemic biology in stroke - implications for translation and treatment","volume":"18","author":"Tiedt","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/s1474-4422(22)00519-1","article-title":"Thrombolysis for acute ischaemic stroke: current status and future perspectives","volume":"22","author":"Tsivgoulis","year":"2023","journal-title":"Lancet Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e231455","DOI":"10.1001\/jamanetworkopen.2023.1455","article-title":"Estimated burden of stroke in China in 2020","volume":"6","author":"Tu","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"B65","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41392-022-00917-z","article-title":"Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia\/reperfusion","volume":"7","author":"Tuo","year":"","journal-title":"Signal Transduct. Target Ther."},{"key":"B66","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/med.21817","article-title":"Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications","volume":"42","author":"Tuo","year":"","journal-title":"Med. Res. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jama.2022.1420","article-title":"What is acute ischemic stroke?","volume":"327","author":"Walter","year":"2022","journal-title":"Jama"},{"key":"B68","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1021\/acs.jmedchem.0c01704","article-title":"Reactive oxygen species (ROS)-Responsive prodrugs, probes, and theranostic prodrugs: applications in the ROS-related diseases","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/svn-2021-001374","article-title":"China stroke statistics: an update on the 2019 report from the national center for healthcare quality management in neurological diseases, China national clinical research center for neurological diseases, the Chinese stroke association, national center for chronic and non-communicable disease control and prevention, Chinese center for disease control and prevention and institute for global neuroscience and stroke collaborations","volume":"7","author":"Wang","year":"2022","journal-title":"Stroke Vasc. Neurol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e2210144","DOI":"10.1002\/adma.202210144","article-title":"A thrombin-activated peptide-templated nanozyme for remedying ischemic stroke via thrombolytic and neuroprotective actions","author":"Wang","year":"2023","journal-title":"Adv. Mater"},{"key":"B71","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1038\/s41467-023-43070-z","article-title":"Pathogenesis-adaptive polydopamine nanosystem for sequential therapy of ischemic stroke","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/s1474-4422(18)30500-3","article-title":"Stroke in China: advances and challenges in epidemiology, prevention, and management","volume":"18","author":"Wu","year":"2019","journal-title":"Lancet Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1161\/circresaha.121.319948","article-title":"Advances in acute ischemic stroke therapy","volume":"130","author":"Xiong","year":"2022","journal-title":"Circ. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1021\/acsnano.9b01798","article-title":"Sequentially site-specific delivery of thrombolytics and neuroprotectant for enhanced treatment of ischemic stroke","volume":"13","author":"Xu","year":"2019","journal-title":"ACS Nano"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e2100028","DOI":"10.1002\/adhm.202100028","article-title":"pH-sensitive, cerebral vasculature-targeting hydroxyethyl starch functionalized nanoparticles for improved angiogenesis and neurological function recovery in ischemic stroke","volume":"10","author":"Yang","year":"2021","journal-title":"Adv. Healthc. Mater"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMoa2001123","article-title":"Endovascular thrombectomy with or without intravenous Alteplase in acute stroke","volume":"382","author":"Yang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1021\/acsnano.2c11363","article-title":"Reactive oxygen species-responsive transformable and triple-targeting butylphthalide nanotherapy for precision treatment of ischemic stroke by normalizing the pathological microenvironment","volume":"17","author":"Yang","year":"2023","journal-title":"ACS Nano"},{"key":"B78","doi-asserted-by":"publisher","first-page":"100406","DOI":"10.1016\/j.lanwpc.2022.100406","article-title":"Rates of intravenous thrombolysis and endovascular therapy for acute ischaemic stroke in China between 2019 and 2020","volume":"21","author":"Ye","year":"2022","journal-title":"Lancet Reg. Health West Pac"},{"key":"B79","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12974-022-02551-6","article-title":"NOX2-mediated reactive oxygen species are double-edged swords in focal cerebral ischemia in mice","volume":"19","author":"Yingze","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"B80","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ana.26547","article-title":"Tenecteplase improves reperfusion across time in large vessel stroke","volume":"93","author":"Yogendrakumar","year":"2023","journal-title":"Ann. Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1056\/NEJMoa2118191","article-title":"Endovascular therapy for acute stroke with a large ischemic region","volume":"386","author":"Yoshimura","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jconrel.2023.08.039","article-title":"Surface-tethered ROS-responsive micelle backpacks for boosting mesenchymal stem cell vitality and modulating inflammation in ischemic stroke treatment","volume":"362","author":"You","year":"2023","journal-title":"J. Control Release"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1021\/acsami.1c19820","article-title":"Bioresponsive polyphenol-based nanoparticles as thrombolytic drug carriers","volume":"14","author":"Yu","year":"","journal-title":"ACS Appl. Mater Interfaces"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1058753","DOI":"10.3389\/fncel.2022.1058753","article-title":"Perspective insights into hydrogels and nanomaterials for ischemic stroke","volume":"16","author":"Yu","year":"","journal-title":"Front. Cell Neurosci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.actbio.2021.12.009","article-title":"Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection","volume":"140","author":"Yu","year":"","journal-title":"Acta Biomater."},{"key":"B86","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1021\/acsnano.1c04753","article-title":"Targeted treatment of ischemic stroke by bioactive nanoparticle-derived reactive oxygen species responsive and inflammation-resolving nanotherapies","volume":"15","author":"Yuan","year":"2021","journal-title":"ACS Nano"},{"key":"B87","doi-asserted-by":"publisher","first-page":"120297","DOI":"10.1016\/j.biomaterials.2020.120297","article-title":"Nanomedicine progress in thrombolytic therapy","volume":"258","author":"Zenych","year":"2020","journal-title":"Biomaterials"},{"key":"B88","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/svn-2018-000226","article-title":"Ischaemic stroke etiological classification system: the agreement analysis of CISS, SPARKLE and TOAST","volume":"4","author":"Zhang","year":"2019","journal-title":"Stroke Vasc. Neurol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jconrel.2021.06.043","article-title":"Thrombus-targeted nanoparticles for thrombin-triggered thrombolysis and local inflammatory microenvironment regulation","volume":"339","author":"Zhang","year":"2021","journal-title":"J. Control Release"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1177\/0271678x16658491","article-title":"Augmentation of poly(ADP-ribose) polymerase-dependent neuronal cell death by acidosis","volume":"37","author":"Zhang","year":"2017","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B91","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s11427-021-1971-x","article-title":"Ultrasound-induced biophysical effects in controlled drug delivery","volume":"65","author":"Zhang","year":"","journal-title":"Sci. China Life Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bioactmat.2022.02.033","article-title":"Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery","volume":"16","author":"Zhang","year":"","journal-title":"Bioact. Mater"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e1903060","DOI":"10.1002\/smll.201903060","article-title":"Remote light-responsive nanocarriers for controlled drug delivery: advances and perspectives","volume":"15","author":"Zhao","year":"2019","journal-title":"Small"},{"key":"B94","doi-asserted-by":"publisher","first-page":"100986","DOI":"10.1016\/j.nantod.2020.100986","article-title":"Biomimetic fibrin-targeted and H(2)O(2)-responsive nanocarriers for thrombus therapy","volume":"35","author":"Zhao","year":"2020","journal-title":"Nano Today"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.2147\/ijn.S43589","article-title":"Potential and problems in ultrasound-responsive drug delivery systems","volume":"8","author":"Zhao","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"B96","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.7150\/thno.73421","article-title":"Targeted delivery of nanomedicines for promoting vascular regeneration in ischemic diseases","volume":"12","author":"Zhuang","year":"2022","journal-title":"Theranostics"}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2023.1329959\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T23:37:03Z","timestamp":1706830623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2023.1329959\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":96,"alternative-id":["10.3389\/fbioe.2023.1329959"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2023.1329959","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,2]]},"article-number":"1329959"}}